Fluvastatin Enhances the Inhibitory Effects of a Selective AT1 Receptor Blocker, Valsartan, on Atherosclerosis

Hypertension - United States
doi 10.1161/01.hyp.0000145179.44166.0f
Full Text
Abstract

Available in full text

Date
Authors
Publisher

Ovid Technologies (Wolters Kluwer Health)

Related search

Effects of Valsartan, an Angiotensin II Receptor Blocker, on Coronary Atherosclerosis in Patients With Acute Myocardial Infarction Who Receive an Angiotensin-Converting Enzyme Inhibitor

Circulation Journal
MedicineCardiovascular MedicineCardiology
2012English

The Non-Biphenyl-Tetrazole AT1 Receptor Blocker Eprosartan Is a Unique and Robust Inverse Agonist of the Active State of AT1 Receptor

British Journal of Pharmacology
Pharmacology
2018English

Effect of the Angiotensin Receptor Blocker Valsartan on Morbidity and Mortality in Heart Failure: The Valsartan Heart Failure Trial (Val-HeFT)

Circulation
Cardiovascular MedicinePhysiologyCardiology
2000English

Angiotensin II Type 1 (AT1) Receptor Deficiency Halts the Progression of Age-Related Atherosclerosis in Hypercholesterolemia: Molecular Link Between the AT1 Receptor and Hypercholesterolemia

Hypertension Research
Internal MedicineCardiovascular MedicinePhysiologyCardiology
2008English

The Impact of Dose of the Angiotensin-Receptor Blocker Valsartan on the Post-Myocardial Infarction Ventricular Remodeling: Study Protocol for a Randomized Controlled Trial

Trials
MedicinePharmacology
2011English

Effects of an Inorganic Ca2+-Channel Blocker (Lanthanum) on Experimental Atherosclerosis in Rabbits

The Journal of Japan Atherosclerosis Society
1983English

Combined Inhibitory Effects of Celecoxib and Fluvastatin on the Growth of Human Hepatocellular Carcinoma Xenografts in Nude Mice

Journal of International Medical Research
BiochemistryMedicineCell Biology
2010English

Effects of a Highly Selective Acetylcholine-Activated K+ Channel Blocker on Experimental Atrial Fibrillation

Circulation: Arrhythmia and Electrophysiology
MedicineCardiovascular MedicinePhysiologyCardiology
2011English

Internalization of Constitutively Active N111G Mutant of AT1 Receptor Induced by Angiotensin II–Receptor Antagonists Candesartan, Losartan, and Telmisartan: Comparison With Valsartan

Journal of Pharmacological Sciences
Molecular MedicinePharmacology
2010English

Amanote Research

Note-taking for researchers

Follow Amanote

© 2025 Amaplex Software S.P.R.L. All rights reserved.

Privacy PolicyRefund Policy